ACMD advice on Hepatitis C and Human Immunodeficiency Virus point of care tests
Information
Type
Meeting Statement
Regulated products
Medical Devices
Published
June 21, 2022
Last updated
June 21, 2022
Description
The TGA asked the ACMD to consider acceptable levels of sensitivity and specificity for Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) PoCTs
Tags
Organization
Country / Region
Australia
License
Other (Non-Commercial)